As the Mississippi Senate considers a bill that would ban the use of pharmaceuticals and sex reassignment surgery for minors who think they are experiencing gender dysphoria, the state’s leading health coverage company has taken a firm stance against the procedures.
The Mississippi Division of Medicaid said it agreed with a report from the Florida Agency for Health Care Administration (pdf) concluding that there is a lack of conclusive evidence to support medical intervention for gender dysphoria in children and adolescents.
Read more at The Epoch Times.
Get up to speed with the threats facing healthcare – and how we’re protecting patients and physicians.
"*" indicates required fields